| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.089 | 0.1 |